Abstract
Purpose: Normative scores (norms) allow for comparisons between population(s) of interest and the general population, which is useful for burden of disease studies and cost-effectiveness analysis. The primary aim of this study was to estimate US visual analogue scale (EQ VAS) and utility-based norms for the EQ-5D-5L using the face-to-face sample. The secondary aim was to compare norms estimated in the face-to-face and online populations. Methods: This study estimated population norms from two general population surveys: (a) face-to-face and (b) online. In these surveys, respondents provided their health state using the EQ-5D-5L health classifier and the EQ VAS. Descriptive statistics, including mean, standard deviation (SD), 95% confidence interval, and median for the 5L utility and EQ VAS were estimated for each sample and across relevant respondent characteristics to serve as the basis for US EQ-5D-5L norms Results: Face-to-face sample respondents (n = 1134) were representative of the US adult general population. In this sample, mean (SD) utility decreased with increasing age until age 45 or greater (age 45–54: 0.816 (0.249) age 55–64: 0.815 (0.243) age 65–74: 0.824 (0.217) age 75 + : 0.811 (0.218)). With increasing age, more problems were reported on all dimensions except anxiety/depression; a smaller proportion of respondents age 65 and older reported problems with anxiety/depression (23.8%) as compared to the youngest respondents (42.1%). Online (n = 2018) mean utility and EQ VAS values were consistently lower than the face-to-face sample. Conclusions: The availability of US EQ-5D-5L norms facilitates interpretation and understanding of general population and patient health.
| Original language | English |
|---|---|
| Pages (from-to) | 803-816 |
| Number of pages | 14 |
| Journal | Quality of Life Research |
| Volume | 30 |
| Issue number | 3 |
| Early online date | 6 Oct 2020 |
| DOIs | |
| Publication status | Published - Mar 2021 |
Bibliographical note
Funding Information:Funding was provided by the EuroQol Group. This work was completed while Ruixuan was a graduate student at the University of Illinois at Chicago, during which she was supported by the UIC Dean’s Dissertation Fellowship and PhRMA Foundation Pre-Doctoral Health Outcomes Fellowship.
Publisher Copyright:
© 2020, The Author(s).